What is bone marrow concentrate (BMC) therapy?
BMC therapy is a minimally invasive procedure that relieves pain and has been shown to promote long-lasting healing of musculoskeletal conditions using your body’s own cells and growth factors. [1] [2] [3] Research institutions and health care providers around the world have made tremendous scientific advances to make pain relief a reality, without the need for surgical intervention. As an Orthobiologics provider, your physician is able to take advantage of your body’s natural ability to heal by concentrating healthy mesenchymal stromal cells, also known as medicinal signaling cells (MSCs), that can be found in your bone marrow and other tissue sources.[1] [4] Laboratory and clinical research has shown that it is possible to use adult MSCs to restore function to degenerative joints and tendons. [4]
BMC therapy is a safe and effective treatment for a variety of conditions due to its autologous nature, meaning it is derived directly from your body for your treatment. [5] [6] [7] [8] [9]
What are MSCs?
Who should consider BMC therapy?
What can you expect during the procedure?
What are the benefits of BMC therapy?
- Minimally invasive, non-surgical procedure
- Enhanced healing with your own natural healing factors
- Extremely low incidence of side effects
Is there any downtime after a BMC procedure?
When can I expect pain relief?
What body parts and conditions can be treated with bone marrow?
Foot & Ankle
- Chondral Defects [12]
- Tendonopathy [19]
- Ligament [19]
- Open Fracture [20]
- OA [19]
Spine
- Discogenic back pain [21]
- Degenerative disc disease (DDD) [22]
Shoulder
- Partial and complete tear [3]
- Rotator Cuff [23]
- Tendinopathy [3]
- OA [3]
Hip
- Osteonecrosis of Hip [14]
- Osteonecrosis of Femoral Head [15]
Knee
- Osteoarthritis [24]
- Chondral defects [13]
- ACL tears [10]
- Tendinopathy [17]
Are all bone marrow treatments the same?
Does my insurance cover BMC therapy?
How much does BMC therapy cost?
Is BMC therapy FDA approved?
REFERENCES:
QR Code (Links organized by body part; also includes additional references)
[4] Caplan, A. I., & Correa, D. (2011). The MSC: An Injury Drugstore. Cell Stem Cell, 9(1), 11–15. https://doi.org/10.1016/j.stem.2011.06.008
[10] Centeno, C., Al-Sayegh, H., Freeman, M., & Centeno, C. (2015). Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. Journal of Pain Research, 437. https://doi.org/10.2147/jpr.s86244
[11] Wells, K., BA, Klein, M., MD, Hurwitz, N., BS, Santiago, K., BA, Cheng, J., PhD, Abutalib, Z., MHS, . . . Lutz, G., MD. (2020). Cellular and Clinical Analyses of Autologous Bone Marrow Aspirate Injectate for Knee Osteoarthritis: A Pilot Study [Abstract]. PM&R. doi:https://doi.org/10.1002/pmrj.12429 (Abstract only)
[12] Chahla, J., Cinque, M. E., Schon, J. M., Liechti, D. J., Matheny, L. M., Laprade, R. F., & Clanton, T. O. (2016). Bone marrow aspirate concentrate for the treatment of osteochondral lesions of the talus: a systematic review of outcomes. Journal of Experimental Orthopaedics, 3(1). https://doi.org/10.1186/s40634-016-0069-x
[14] Houdek, M. T., Wyles, C. C., Collins, M. S., Howe, B. M., Terzic, A., Behfar, A., & Sierra, R. J. (2018). Stem Cells Combined With Platelet-rich Plasma Effectively Treat Corticosteroid-induced Osteonecrosis of the Hip. Clinical Orthopaedics and Related Research, 476(2), 388–397. https://doi.org/10.1007/s11999.0000000000000033
[23] Centeno, C., Fausel, Z., Stemper, I., Azuike, U., & Dodson, E. (2020). A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis. Stem Cells International, 2020, 1–10. https://doi.org/10.1155/2020/5962354
[24] Emadedin, M., Narges, L., Maede, L. G., Hosseini, S., Baharvand, H., & Aghdami, N. (2018). Intra-articular implantation of autologous bone marrow–derived mesenchymal stromal cells to treat knee osteoarthritis: A randomized, triple-blind, placebo-controlled phase 1/2 clinical trial [Abstract]. Cytotherapy, 20(10), P1238-P1246. doi:https://doi.org/10.1016/j.jcyt.2018.08.005